For citations:
Shamkhalova M.Sh., Shestakova M.V. Efficacy and safety of oral semaglutide in Russian patients with type 2 diabetes: subgroup analysis of PIONEER 1, 2, 3 trials. Diabetes mellitus. 2022;25(3):204-214. (In Russ.) https://doi.org/10.14341/DM12941
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
